bioAffinity Technologies, Inc. (BIAF)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 28.21M |
| Enterprise value | 26.97M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.46 |
| Price/book (mrq) | 5.81 |
| Enterprise value/revenue | 10.65 |
| Enterprise value/EBITDA | -0.21 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 33.88% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 3.6200 |
| 52-week low 3 | 0.9550 |
| 50-day moving average 3 | 2.2519 |
| 200-day moving average 3 | 1.7316 |
Share statistics
| Avg vol (3-month) 3 | 258.74k |
| Avg vol (10-day) 3 | 136.96k |
| Shares outstanding 5 | 11.51M |
| Implied shares outstanding 6 | 11.51M |
| Float 8 | 7.57M |
| % held by insiders 1 | 35.04% |
| % held by institutions 1 | 2.08% |
| Shares short (30 Apr 2024) 4 | 395.02k |
| Short ratio (30 Apr 2024) 4 | 2.04 |
| Short % of float (30 Apr 2024) 4 | 6.63% |
| Short % of shares outstanding (30 Apr 2024) 4 | 3.43% |
| Shares short (prior month 28 Mar 2024) 4 | 55.13k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -105.83% |
Management effectiveness
| Return on assets (ttm) | -48.85% |
| Return on equity (ttm) | -99.85% |
Income statement
| Revenue (ttm) | 2.53M |
| Revenue per share (ttm) | 0.29 |
| Quarterly revenue growth (yoy) | 94,246.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -7.6M |
| Net income avi to common (ttm) | -7.94M |
| Diluted EPS (ttm) | -0.9100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.82M |
| Total cash per share (mrq) | 0.25 |
| Total debt (mrq) | 1.58M |
| Total debt/equity (mrq) | 32.51% |
| Current ratio (mrq) | 1.77 |
| Book value per share (mrq) | 0.52 |
Cash flow statement
| Operating cash flow (ttm) | -6.04M |
| Levered free cash flow (ttm) | -3.61M |
© 2024 Yahoo. All rights reserved.